Skip to main content
. 2020 Nov 28;11(4):961–977. doi: 10.1016/j.apsb.2020.11.020

Figure 5.

Figure 5

(A) Schematic illustration of PBEAGA-CPT with rapidly transcytosis ability and deep tumor penetration ability. (B) In vivo real-time permeability of PBEAGA-Cy5-CPT from the blood vessel to HepG2 xenograft tumor in a mouse ear after intravenous injection. Reprinted with the permission from Ref. 70. Copyright © 2020, Elsevier Ltd.